Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

MY BMS CASES

LOG IN

CREATE ACCOUNT

INDICATION
  • NULOJIX (in combination with basiliximab induction, mycophenolate mofetil [MMF], and corticosteroids) is indicated for prophylaxis of organ rejection in adults receiving a kidney transplant
  • Use NULOJIX only in patients who are Epstein-Barr virus (EBV) seropositive
  • Use of NULOJIX for prophylaxis of organ rejection in transplanted organs other than kidney has not been established

Support Center icon
8 am to 8 pm ET,
Monday - Friday
Schedule a Call iconSchedule a Call

Schedule a call from a Care Coordinator

Request a Visit icon Request a Visit

Request a visit from a BMS Access & Reimbursement Manager

 
BMS Logo

©2017 Bristol-Myers Squibb Company. All rights reserved. Access Support and Access Support logo are registered trademarks of Bristol-Myers Squibb Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 03/17.

721US1605616-01-01 03/17